Zobrazeno 1 - 10 of 73 pro vyhledávání: '"L Sanromán"'
1
OP26 Impact of telemonitoring on the management of Inflammatory Bowel Disease in Spain: a multicenter TECCU clinical trial
Autor: M Aguas Peris, J Del Hoyo, R Vicente, M Barreiro-de Acosta, L Melcarne, A Hernández-Camba, E Alfambra, L Madero, B Sicilia, M Chaparro, M D Martín-Arranz, R Pajares, F Mesonero, M Mañosa, P Martínez, S Chacón, J Tosca, S Marín, L Sanromán, M Calvo, D Monfort, E Saiz, Y Zabana, I Guerra, P Varela, R Faubel, P Corsino, S Porto-Silva, E Brunet, A Gutiérrez, P Nos
Publikováno v: Journal of Crohn's and Colitis. 17:i35-i37
Background Telemedicine is not consistently superior to standard care in the management of inflammatory bowel disease (IBD). Non-inferiority is an acceptable outcome if telemedicine improves the efficacy and efficiency of care. Owing to the positive
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::be9b6c6b46b41ff151bc3e8c23a874d0
https://doi.org/10.1093/ecco-jcc/jjac190.0026
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
P591 Therapeutic management in inflammatory bowel disease: Differences in two IBD inception cohorts: 1991–93 and 2010–11 enrolled in the north-west of Spain
Autor: J Martinez-Cadilla, Hernández, M Figueira, J I Rodriguez-Prada, M L De Castro Parga, J.R. Pineda, L. Sanromán, Santos Pereira
Publikováno v: Journal of Crohn's and Colitis. 14:S493-S494
Background The treatment of IBD has dramatically changed in the last two decades, with the advent of immunosuppressive and biological drugs. The goal of therapy remains to achieve and maintain disease remission, diminishing disease outbreaks as well.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c023c45e5f39f1b1ae14ea394ebbf9fe
https://doi.org/10.1093/ecco-jcc/jjz203.719
Zobrazit plný text záznamu
6
P572 The influence of beliefs about medication in therapeutic adherence among patients with inflammatory bowel disease
Autor: L. Sanromán, Santos Pereira, M Figueira, I Rodríguez-Prada, M L De Castro Parga, J Martinez-Cadilla, C Alvarez-Smith, Vicent Hernandez, J.R. Pineda
Publikováno v: Journal of Crohn's and Colitis. 15:S531-S531
Background Medication nonadherence in inflammatory bowel disease (IBD) is common and has a negative impact on disease outcome. It is currently not clear whether in patients with IBD, the opinions, beliefs and attitudes towards medicines determine an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::29574ceced3f3481b03759f87c5c06e8
https://doi.org/10.1093/ecco-jcc/jjab076.693
Zobrazit plný text záznamu
7
P565 Illness perception as a clinical tool to detect mood disturbances (anxiety or depression) in inflammatory bowel disease patients
Autor: J.R. Pineda, J Martinez-Cadilla, M Figueira, L. Sanromán, Vicent Hernandez, J I Rodriguez-Prada, D Pereyra, Santos Pereira, M L De Castro Parga
Publikováno v: Journal of Crohn's and Colitis. 15:S526-S526
Background In patients suffering from inflammatory bowel disease (IBD), a prevalence of anxiety and/or depression of 30–35% has been reported in phases of clinical inactivity, reaching up to 60–80% in the flare-ups. Moreover, the presence of psyc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::09ddd6cde97240f28da2b8a554297b12
https://doi.org/10.1093/ecco-jcc/jjab076.686
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
European experience with methotrexate treatment in Crohn’s disease
Autor: Juan R. Pineda, L. Sanromán, Gregorios A. Paspatis, Selwyn Odes, N. Jojic, Ioannis E. Koutroubakis, Konstantinos Papamichael, Uri Kopylov, Konstantinos H. Katsanos, I. Kaimakliotis, Christien J. van der Woude, Konstantinos Karmiris, Epameinondas V. Tsianos, Konstantina Strongili, Gerassimos J. Mantzaris, D. Bojic, Vicent Hernandez, Neofytos P. Papageorgiou, Shomron Ben-Horin, Dimitrios K. Christodoulou, Gionata Fiorino
Publikováno v: European Journal of Gastroenterology & Hepatology, 28(7), 802-806. Lippincott Williams & Wilkins
IntroductionMethotrexate (MTX) has been utilized for the treatment of Crohn's disease (CD) for decades. Nevertheless, current data provide equivocal evidence on the efficacy of MTX in CD.The aims of this study were to describe the efficacy of MTX for
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29d7fbb87bd4ad698713b3f4c2d7aa41
https://doi.org/10.1097/meg.0000000000000609
Zobrazit plný text záznamu
10
P741 Incidence and clinical phenotype of inflammatory bowel disease in the north–west of Spain (Vigo) between 1991 and 2011
Autor: M Figueira, J I Rodriguez-Prada, M L De Castro Parga, V De Castro Luisa Hernández, Santos Pereira, J.R. Pineda, L. Sanromán, J Martínez Cadilla
Publikováno v: Journal of Crohn's and Colitis. 14:S593-S593
Background The incidence of inflammatory bowel disease (IBD) seems to have stabilised in the last two decades in some western countries. Our aim was to analyse changes in the epidemiology of IBD between 1991 and 2011 in the area of Vigo (north–west
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b931cd6962609124e4d46f40602d7554
https://doi.org/10.1093/ecco-jcc/jjz203.869
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje